1 Min Read
May 26 (Reuters) - Rexahn Pharmaceuticals Inc:
* Rexahn Pharmaceuticals files for mixed shelf offering of up to $150 million - sec filing Source text (bit.ly/2s4PKc4) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.